Supplementary Table 1 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Composition and rates of all detectable genomic features detectable through the Caris diagnostic platform.

Guardado en:

Detalles Bibliográficos
Autor principal:	Justin Hwang (15925675) (author)
Otros Autores:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Publicado:	2025
Materias:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes